NCT00608738 Using Whole-Person-Care Guide in Patients Receiving Care for Cancer or Complications From Cancer Treatment Status COMPLETED Phase NA
NCT00603304 Complementary and Alternative Medicine for Urological Symptoms(CAMUS) Status COMPLETED Phase PHASE3
NCT00602433 Hormone Changes in Women With Stage IIIB or Stage IV Non-Small Cell Lung Cancer Receiving Erlotinib Status COMPLETED Phase N/A
NCT00590902 Ph II OSI-774 (Erlotinib,Tarceva) In Advanced Bronchioloalveolar Cell Lung Cancer Status COMPLETED Phase PHASE2
NCT00588523 Intensive Chemotherapy and Autotransplantation for Patients With Newly Diagnosed Anaplastic Oligodendroglioma Status COMPLETED Phase PHASE2
NCT00585546 Harefield Recovery Protocol Study for Patients With Refractory Chronic Heart Failure Status TERMINATED Phase PHASE1
NCT00565383 The Effect of Combined Spinal-Epidural Analgesia on the Success of External Cephalic Version (ECV) for Breech Position Status COMPLETED Phase NA
NCT00558831 Study of Benzoyl Peroxide Cream for Mild to Moderate Acne Vulgaris Status COMPLETED Phase NA
NCT00539071 High Dose Risperidone Consta for Patients With Schizophrenia With Poor Response to Risperidone Status COMPLETED Phase PHASE4
NCT00536952 Pilot Study of Pulmozyme (rhDNase) in Patients With Head and Neck Cancers Treated With Radiation Therapy + Chemotherapy Status UNKNOWN Phase EARLY_PHASE1
NCT00532740 Radiolabeled Glass Beads in Treating Patients With Metastatic Liver Cancer That Cannot Be Removed by Surgery Status COMPLETED Phase N/A
NCT00530010 Radiolabeled Glass Beads in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery Status COMPLETED Phase N/A
NCT00520312 Magnetic Resonance Imaging to Identify Characteristics of Plaque Build-Up in People With Peripheral Arterial Disease Status COMPLETED Phase N/A
NCT00516282 VNP40101M and Temozolomide in Treating Patients With Progressive or Relapsed Malignant Glioma Status TERMINATED Phase PHASE1
NCT00510081 An Evaluation of an Injectable Material for Correction of Wrinkles Status WITHDRAWN Phase PHASE3